Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M56.9Revenue $M0.3Net Margin (%)--Altman Z-Score21.9
Enterprise Value $M12.8EPS $-0.5Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.6Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %-49.7Quick Ratio32.7Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-45.3Current Ratio32.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-45.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-48.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M63.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ABIO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABIOFirst Eagle Investment 2010-03-31 Sold Out -0.01%$15.84 - $49.32
($19.1)
$ 0.90-95%Sold Out0
ABIOFirst Eagle Investment 2009-12-31 Reduce$13.5 - $25.92
($18.08)
$ 0.90-95%Reduce 27.96%68,720
ABIOFirst Eagle Investment 2009-09-30 Add0.01%$13.68 - $26.4
($20.88)
$ 0.90-96%Add 62.38%95,387
ABIOFirst Eagle Investment 2009-06-30 Sold Out -0.02%$15.48 - $80.7
($41.17)
$ 0.90-98%Sold Out0
ABIOFirst Eagle Investment 2009-06-30 Add$15.48 - $80.7
($41.17)
$ 0.90-98%Add 24.34%58,742
ABIOFirst Eagle Investment 2009-03-31 Buy 0.02%$23.399 - $39.41
($31.32)
$ 0.90-97%New holding47,242
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABIO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ABIO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BRISTOW MICHAEL RSee Remarks 2015-03-02Sell5,446$0.7126.76 view
Selby Brian L.VP, Finance 2015-03-02Sell1,125$0.7126.76 view
mccormack riley10% Owner 2015-01-16Sell350,000$0.7618.42 view
mccormack riley10% Owner 2015-01-07Sell550,000$0.92-2.17 view
Wheeler Patrick MCFO 2014-09-18Sell8,246$1.31-31.3 view
BRISTOW MICHAEL RPresident and CEO 2014-09-18Sell13,853$1.3-30.77 view
mccormack riley10% Owner 2014-02-04Buy1,000,000$1.7-47.06 view
mccormack riley10% Owner 2013-09-27Sell0$0-47.06 view
Atlas Venture Fund VII L P10% Owner 2012-10-25Sell0$0-47.06 view
Grais Linda SDirector 2010-03-29Sell210,809$7.38-87.8 view

Quarterly/Annual Reports about ABIO:

    News about ABIO:

    Articles On GuruFocus.com
    comment on ABIO Mar 15 2013 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 15 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) May 10 2010 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Nov 16 2009 
    ARCA BIOPHARMA, INC. Reports Operating Results (10-Q) Aug 10 2009 
    ARCA biopharma Inc. Reports Operating Results (10-Q) May 15 2009 
    ARCA biopharma Inc. Reports Operating Results (10-Q) Feb 07 2009 

    More From Other Websites
    ARCA biopharma to Present at the Rodman & Renshaw 17th Annual Global Investment Conference Aug 26 2015
    ARCA BIOPHARMA, INC. Financials Aug 22 2015
    10-Q for ARCA biopharma, Inc. Aug 13 2015
    3 Promising Plays in Healthcare's Most Vibrant Space Aug 13 2015
    ARCA biopharma Announces Second Quarter 2015 Operating Results and Provides Update on Recent... Aug 11 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 11 2015
    ARCA biopharma Announces Second Quarter 2015 Operating Results and Provides Update on Recent... Aug 11 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jul 16 2015
    Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products... Jun 29 2015
    RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech Jun 29 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 23 2015
    ARCA biopharma Announces $37 Million Private Placement Jun 17 2015
    ARCA biopharma Announces Closing of $37 Million Private Placement Jun 17 2015
    ARCA biopharma Announces Closing of $37 Million Private Placement Jun 17 2015
    ARCA biopharma Announces $37 Million Private Placement Jun 12 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K/A, Financial Statements and Exhibits Jun 11 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Jun 11 2015
    ARCA biopharma Announces $37 Million Private Placement Jun 11 2015
    ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events Jun 05 2015
    ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report May 12 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK